Meltzer-Brody Samantha, Jones Ian
UNC Center for Women's Mood Disorder, Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA.
National Centre for Mental Health, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Dialogues Clin Neurosci. 2015 Jun;17(2):207-18. doi: 10.31887/DCNS.2015.17.2/smeltzerbrody.
The perinatal period is a time of high risk for women with unipolar and bipolar mood disorders. We discuss treatment considerations for perinatal mood disorders, including unipolar and bipolar depression as well as postpartum psychosis. We further explore the unique issues faced by women and their families across the full trajectory of the perinatal period from preconception planning through pregnancy and following childbirth. Treatment of perinatal mood disorders requires a collaborative care approach between obstetrics practitioners and mental health providers, to ensure that a thoughtful risk : benefit analysis is conducted. It is vital to consider the risks of the underlying illness versus risks of medication exposure during pregnancy or lactation. When considering medication treatment, attention must be paid to prior medication trials that were most efficacious and best tolerated. Lastly, it is important to assess the impact of individual psychosocial stressors and lifestyle factors on treatment response.
围产期对于患有单相和双相情绪障碍的女性来说是一个高风险时期。我们讨论围产期情绪障碍的治疗考量,包括单相和双相抑郁症以及产后精神病。我们进一步探讨女性及其家庭在从孕前规划到怀孕及产后的整个围产期过程中所面临的独特问题。围产期情绪障碍的治疗需要产科医生和心理健康提供者之间的协作护理方法,以确保进行周全的风险效益分析。考虑潜在疾病的风险与孕期或哺乳期药物暴露的风险至关重要。在考虑药物治疗时,必须关注既往最有效且耐受性最佳的药物试验。最后,评估个体心理社会应激源和生活方式因素对治疗反应的影响也很重要。